Stephanie, Pauline and Sébastien will attend the 2026 HealthTech Trophies on 30 March 2026, joining one of the leading events celebrating HealthTech innovation, young HealthTech companies, and the future of healthcare innovation in France.
This year, the event places a strong focus on the Young HealthTech Company Trophy, highlighting emerging companies that are transforming patient pathways, advancing therapeutic innovation, and reshaping the future of healthcare through science and technology.
A key event for HealthTech innovation
The HealthTech Trophies 2026 bring together entrepreneurs, researchers, investors and healthcare leaders to recognise the most promising companies in the sector. For businesses operating at the intersection of biotech, medtech, digital health and AI, the event is a valuable platform to
showcase innovation and celebrate breakthrough achievements.
For Stephanie, Pauline and Sébastien, attending the 2026 HealthTech Trophies is an
opportunity to follow the latest developments in the HealthTech ecosystem and engage with the companies
and leaders driving innovation in healthcare.
Young HealthTech Company Trophy 2026: shortlisted companies
The Young HealthTech Company Trophy 2026 honours four innovative businesses whose
technologies and scientific approaches reflect the strength of the HealthTech sector.
Adcytherix
Led by Jack Elands, CEO, Adcytherix is a clinical-stage biopharmaceutical company
developing a new generation of antibody-drug conjugates for cancer treatment. Its approach combines
clinically validated payloads, antibodies and linkers to develop therapies designed to be more
effective and better tolerated, while reducing development risk and accelerating delivery to patients.
Nebula Biotech
Led by Mounir Tarek, Nebula Biotech is a CNRS TechBio spin-off focused on making the
“undruggable” proteome druggable. Using proprietary physics-based generative AI, the company’s platform
maps protein conformational dynamics, identifies cryptic and allosteric sites, and supports the
development of first-in-class therapeutic candidates.
TheraSonic
Led by Benoit Larrat, PhD, TheraSonic is built on 15 years of research at the CEA and
CNRS. The company is developing a transcranial focused ultrasound device that temporarily opens the
blood-brain barrier, improving the delivery of innovative therapies for brain diseases, starting with
brain cancer.
ZebraMed
Led by Valerio Laghi, PhD, ZebraMed is a TechBio company combining AI, robotics and
systems biology across whole organisms to predict clinical efficacy before human trials. Its Bio
Foundry is designed to discover life-saving treatments faster and reduce failure rates in clinical
development.
Looking ahead to 30 March
The 2026 HealthTech Trophies will shine a spotlight on the next generation of companies
shaping the future of healthcare. Stephanie, Pauline and Sébastien are pleased to attend this important
HealthTech event and look forward to discovering which company will win the
Young HealthTech Company Trophy 2026.